In no doubt, this study warrants further investigation of the role of Sirt1 in pancreatic cancer development as well as of the chemotherapeutic efficacy of Sirt1 inhibitors in preclinical models of human PDAC, guided by the expression of Sirt1 and Ccar2. The gene discussed is CCAR2; the disease is familial pancreatic carcinoma.